Trust in Science Africa

Trust in Science is a research funding programme designed to build a sustainable, long-term scientific research base in Africa, to deliver medicines that are specific to patient needs. Initially, it is open to scientists working in Kenya, Tanzania and Uganda.

Please select...

The wider aims of Trust in Science Africa are to:

  • Drive sustainable investment in local scientific innovation and capabilities
  • Help translate science into meaningful benefits for patients
  • Deliver breakthrough science to address  health issues for which there is currently no or little treatment
  • Support GSK’s position as healthcare partner of choice for scientists, and establish relationships leading to further collaborations
  • Share talent, technologies and scientific insight between GSK and selected research groups

Funding ideas

We are committed to seeking out the best scientific ideas and funding their development, and are keen to receive applications from both young scientists and established research groups. Applications from all countries will be considered together, and the best applications overall – based on scientific merit - will be chosen for funding by an independent scientific advisory panel. The programme seeks to support scientific research that can rapidly translate into an improvement in the lives of patients. Research proposals related to locally relevant medical needs are especially encouraged.  

Successful proposals will identify areas of mutual interest, in which questions may be answered to deliver breakthroughs in the understanding of specific diseases. We already have substantial research and drug discovery efforts across several major therapeutic areas. Trust in Science is specifically seeking proposals from the following areas of research.

Respiratory and other non-communicable diseases

COPD, asthma: strategies to enhance access to treatment and guideline supported disease management 

Pulmonary fibrosis

Cardiovascular disease (including hypertension, hyperlipidemia, MI, cardiac failure, stroke): strategies to enhance current understanding of disease epidemiology, population relevant genetic risk factors, factors influencing disease outcomes.

Metabolic diseases

Diabetes, obesity, atherosclerosis, cardiac failure

Infectious diseases including TB and HIV

  • New approaches for treating viral (including hepatitis C virus, hepatitus B virus, respiratory syncytial virus, human papilloma virus, HIV) and bacterial infection
  • Initiatives that seek to develop clinical investigators based in health centres outside of primary centres of excellence
  • Neonatal sepsis – initiatives that seek to improve the speed and accuracy of diagnosis and simplify treatment management
  • Tuberculosis

Neglected Tropical Diseases

Tropical diseases (malaria, Human African Trypanosomiasis, leishmaniasis)

Immunology and Inflammation

Epigenetics, rheumatoid arthritis, cytokines and chemokines in disease processes

Biopharmaceuticals

Protein therapeutics including monoclonal antibodies

Other topics

The programme is actively seeking projects in the areas listed above, however if you have an exceptional idea that has the potential to significantly improve patient health, you may submit the proposal together with a clear rationale explaining why it should be considered. Only those ideas that are exceptional will pass through the screening stage.

2014 Trust in Science Africa award winners

2014 Winners of Trust in Science call

Institution and country

Title of project

Dr David Kateete Makarere University, Kampala, Uganda Validation of mycobacterial rhomboid proteases as anti-TB drug/vaccine targets
Dr Clara Wekesa MRC/UVRI Uganda Research Unit on AIDS, Uganda Prevalence and risk factors for liver fibrosis among HIV-infected patients in rural Uganda
Dr Omalla Allan Kenya Medical Research Institute (KEMRI), Kenya In vitro screening of African tropical plant extracts as potential targets if chronic CD4 T-cell activation and the HIV-1 viral reservoir
Dr Bernhard Ogutu Centre for Research in Therapeutic Sciences, Nairobi, Kenya Pharmaco-epidemiology of hypertension therapeutics in selected Kenyan health facilities HT-AGT2
Dr Bruce Kirenga Makarere University, Kampala, Uganda The Uganda Registry for Asthma and COPD (URAC) Project
Dr Samuel Okurut Makarere University, Kampala, Uganda Phenotypic and Functional Characterization of B Cells in Cerebrospinal Fluid and Peripheral Blood of HIV-Associated Cryptococcal Meningitis
Back to top